Number of the records: 1  

proteíny protoonkogénové c-mdm2

  1. SYSd051736
    LBL
      
    00000cz--a2200000n--4500
    005
      
    20250606214343.6
    008
      
    050630|||anznnbabn-----------|-a|a------
    040
      
    $b slo $a DNLM $d BA006 $d BA006 $d BA006
    065
      
    $a D08.811.464.938.750.562
    065
      
    $a D12.776.624.664.700.185
    065
      
    $a D12.776.660.764
    066
      
    $a 01 $c 03
    150
      
    $a proteíny protoonkogénové c-mdm2 $x AD $x AE $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DE $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UL $x UR $2 slo
    450
      
    $w v $a c-mdm2 Proto-Oncogene Protein $2 eng
    450
      
    $w v $a Mdm2 Protein $2 eng
    450
      
    $w v $a proteín Mdm2 $2 slo
    450
      
    $w v $a proteín MDMX $2 slo
    450
      
    $w v $a proteín protoonkogénový c-mdm2 $2 slo
    450
      
    $w v $a proteín 2, dvojminútový myší $2 slo
    665
      
    $a 2006(1991) $2 eng
    680
    9-
    $i An E3 UBIQUITIN LIGASE that interacts with and inhibits TUMOR SUPPRESSOR PROTEIN P53. Its ability to ubiquitinate p53 is regulated by TUMOR SUPPRESSOR PROTEIN P14ARF. $2 eng
    750
    -2
    $a Proto-Oncogene Proteins c-mdm2 $2 eng
    980
      
    $x M
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.